Leila Jaafar, Nuclidium CEO

Swiss and Ger­man ra­dio­phar­ma biotech Nu­clid­i­um col­lects $99M Se­ries B

For the sec­ond day in a row, a Eu­ro­pean ra­dio­phar­ma com­pa­ny said it has bagged a large ven­ture fund­ing round.

Basel and Mu­nich-based start­up Nu­clid­i­um …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.